Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-Current Assets (2018 - 2026)

TELA Bio has reported Non-Current Assets over the past 8 years, most recently at $5.8 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 31.32% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $25.7 million, down 28.08%, while the annual FY2025 figure was $5.8 million, 31.32% down from the prior year.
  • Non-Current Assets for Q4 2025 was $5.8 million at TELA Bio, up from $5.5 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $9.2 million in Q1 2024 and troughed at $3.1 million in Q2 2021.
  • A 5-year average of $5.9 million and a median of $5.6 million in 2022 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 86.0% in 2022 and later plummeted 37.65% in 2025.
  • Year by year, Non-Current Assets stood at $3.5 million in 2021, then surged by 55.0% to $5.4 million in 2022, then rose by 16.9% to $6.3 million in 2023, then skyrocketed by 34.44% to $8.5 million in 2024, then tumbled by 31.32% to $5.8 million in 2025.
  • Business Quant data shows Non-Current Assets for TELA at $5.8 million in Q4 2025, $5.5 million in Q3 2025, and $6.8 million in Q2 2025.